Exact Mass: 425.1863

4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol

C27H24FN3O (425.1903)

Mecinarone

C24H27NO6 (425.1838)

(+)-Cyclotryprostatin B

C23H27N3O5 (425.1951)

Nisamycin

C24H27NO6 (425.1838)

MS000061553

C24H27NO6 (425.1838)

daphnicyclidin N

C24H27NO6 (425.1838)

C24H27NO6

C24H27NO6 (425.1838)

3alpha,6beta-bis(4-methoxybenzoyloxy)tropane|merredissine

C24H27NO6 (425.1838)

Phe Pro Tyr

C23H27N3O5 (425.1951)

Pro Phe Tyr

C23H27N3O5 (425.1951)

Tyr-Pro-Phe

C23H27N3O5 (425.1951)

Pro Tyr Phe

C23H27N3O5 (425.1951)

Alfuzosin hydrochloride (Uroxatral)

C19H28ClN5O4 (425.183)

Tyr Phe Pro

C23H27N3O5 (425.1951)

desmethylnortriptyline glucuronide

C24H27NO6 (425.1838)

Phe Tyr Pro

C23H27N3O5 (425.1951)

Tyr Pro Phe

C23H27N3O5 (425.1951)

SCH 563705

C23H27N3O5 (425.1951)

Fmoc-Glu-OtBu

C24H27NO6 (425.1838)

mecinarone

C24H27NO6 (425.1838)

Fmoc-D-Glu(OtBu)-OH

C24H27NO6 (425.1838)

Fmoc-D-Glu-OtBu

C24H27NO6 (425.1838)

GW788388

C25H23N5O2 (425.1852)

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-6-((((4-NITROBENZYL)OXY)CARBONYL)AMINO)HEXANOIC ACID

C19H27N3O8 (425.1798)

1,3-Benzodioxole-5-carboxamide, N-(((2-(1-(phenylmethyl)-4-piperdinyl) ethyl)amino)thioxomethyl)-

C23H27N3O3S (425.1773)

(2S,3S,5S)-5-Amino-2-(N-((5-thiazolyl)-methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane

C23H27N3O3S (425.1773)

2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl Acetate

C23H27N3O3S (425.1773)

Fmoc-Glu(OtBu)-OH

C24H27NO6 (425.1838)

Fmoc-N-(tert-butyloxycarbonylethyl)-glycine

C24H27NO6 (425.1838)

Boc-Glu(ofm)-OH

C24H27NO6 (425.1838)

Alfuzosin hydrochloride

C19H28ClN5O4 (425.183)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Alfuzosin (SL 77499-10) hydrochloride is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin hydrochloride relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin hydrochloride can be used in study of benign prostatic hyperplasia (BPH)[1][2].

Fmoc-β-homo-Asp(OtBu)-OH

C24H27NO6 (425.1838)

Fmoc-N-Me-Asp(OtBu)-OH

C24H27NO6 (425.1838)

N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl]-N-methyloxolane-2-carboxamide,hydrochloride

C19H28ClN5O4 (425.183)

boc-d-glu-ofm

C24H27NO6 (425.1838)

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-aspartic acid 4-(1,1-dimethylethyl) ester

C24H27NO6 (425.1838)

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid

C24H27NO6 (425.1838)

β-Casomorphin (1-3)

C23H27N3O5 (425.1951)

GlutaMic acid, N-[[(4-Methoxyphenyl)thio]carbonyl]-, bis(1,1-diMethylethyl) ester

C21H31NO6S (425.1872)

Platencin

C24H27NO6 (425.1838)

A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the polycyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase.

(2S,4R)-N-[2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidin-1-ium-2-carboxamide

C18H34ClN2O5S+ (425.1877)

(Z)-1-[6-[2-(dimethylamino)ethoxy]-4,7-dimethoxy-1-benzofuran-5-yl]-3-(4-methoxyphenyl)prop-2-en-1-one

C24H27NO6 (425.1838)

4-[(2E)-2-{2-[6-hydroxy-3-methyl-2-oxo-8-(piperidin-1-yl)-2,3-dihydro-7H-purin-7-yl]ethylidene}hydrazinyl]benzoic acid

C20H23N7O4 (425.1811)

l-Tyrosyl-l-prolyl-l-phenylalanine

C23H27N3O5 (425.1951)

[2-[4-[4-(2-Methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl] 2,3-dihydro-1,4-dioxine-5-carboxylate

C24H27NO6 (425.1838)

1-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-furanylmethyl)-3-(2-oxolanylmethyl)thiourea

C23H27N3O3S (425.1773)

3-[(2E)-2-[[3-Ethoxy-4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]methylidene]hydrazinyl]benzoic acid

C23H27N3O5 (425.1951)

N-[(E)-2,3-dihydro-1,4-benzodioxin-6-ylmethylideneamino]-N-(2-hydroxyphenyl)octanediamide

C23H27N3O5 (425.1951)

Phe-Pro-Tyr

C23H27N3O5 (425.1951)

Phe-Tyr-Pro

C23H27N3O5 (425.1951)

N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide;hydron;chloride

C19H28ClN5O4 (425.183)

4-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

4-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

4-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

4-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

4-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

4-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-(4-methoxyphenyl)-2-[4-morpholinyl(oxo)methyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

C23H27N3O5 (425.1951)

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-7-(4-methoxyphenyl)-2-(morpholine-4-carbonyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

C23H27N3O5 (425.1951)

2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C23H27N3O5 (425.1951)

2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

4-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzamide

C22H24FN5O3 (425.1863)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C23H27N3O5 (425.1951)

3-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-methylsulfonyl-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile

C23H27N3O3S (425.1773)

Tyr-Phe-Pro

C23H27N3O5 (425.1951)

Pro-Phe-Tyr

C23H27N3O5 (425.1951)

Pro-Tyr-Phe

C23H27N3O5 (425.1951)

9-benzyl-2-butyl-1-(2-chlorophenyl)-9H-beta-carbolin-2-ium

C28H26ClN2+ (425.1784)

N-[(Z)-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enylidene]amino]-N-(2-hydroxyphenyl)heptanediamide

C23H27N3O5 (425.1951)

LPE 12:2;O2

C17H32NO9P (425.1815)

ST 19:3;O3;Tau

C21H31NO6S (425.1872)

H-Val-Pro-Pro-OH (TFA)

C17H26F3N3O6 (425.1774)

H-Val-Pro-Pro-OH (TFA), a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM.

1-hydroxy-2,7-dimethoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H27N3O5 (425.1951)

(2s)-2-[(9ar)-3-hexanoyl-9a-methyl-2,9-dioxo-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinolin-7-yl]propanoic acid

C24H27NO6 (425.1838)

(1r,2r,12r,15s)-1-hydroxy-2,7-dimethoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H27N3O5 (425.1951)

(20s,21s)-21-hydroxy-5,6,10,11-tetramethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-16-ium-16-olate

C24H27NO6 (425.1838)

2-[3-hexanoyl-9a-methyl-2,9-dioxo-6-(prop-1-en-1-yl)furo[3,2-g]isoquinolin-7-yl]propanoic acid

C24H27NO6 (425.1838)

(4r)-4-[(1r,4z,8z,10s,13r,15r)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-3-(hydroxymethyl)-1,3-thiazolidin-2-one

C21H31NO6S (425.1872)

3-(2,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl)-1,4-dihydroxy-5-{2-hydroxy-7-oxabicyclo[4.1.0]hept-2-en-3-yl}pyridin-2-one

C24H27NO6 (425.1838)

2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,8s)-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO6 (425.1838)

(1s,2s,12s,15s)-1-hydroxy-2,7-dimethoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H27N3O5 (425.1951)

2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,6r,8s)-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO6 (425.1838)

(1r,2s,12r,15r)-1-hydroxy-2,7-dimethoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H27N3O5 (425.1951)

21-hydroxy-5,6,10,11-tetramethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-16-ium-16-olate

C24H27NO6 (425.1838)

2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s)-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO6 (425.1838)

7-[4-(5-cyclohexylpenta-2,4-dienamido)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]hepta-2,4,6-trienoic acid

C24H27NO6 (425.1838)

(2e,4e,6e)-7-[(1s,2r,6r)-4-{[(2e,4e)-5-cyclohexyl-1-hydroxypenta-2,4-dien-1-ylidene]amino}-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]hepta-2,4,6-trienoic acid

C24H27NO6 (425.1838)

3-[(1s,2s,4ar,8as)-2,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-1,4-dihydroxy-5-{2-hydroxy-7-oxabicyclo[4.1.0]hept-2-en-3-yl}pyridin-2-one

C24H27NO6 (425.1838)

(2r)-2-[(9ar)-3-hexanoyl-9a-methyl-2,9-dioxo-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinolin-7-yl]propanoic acid

C24H27NO6 (425.1838)